Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-28T10:08:36.507Z Has data issue: false hasContentIssue false

Aggressive angiomyxoma of larynx: case report and literature review

Published online by Cambridge University Press:  04 December 2009

D C Sylvester*
Affiliation:
Department of Otolaryngology, The Leeds General Infirmary, UK
S Kortequee
Affiliation:
Department of Otolaryngology, Pinderfields Hospital, Wakefield, UK
J W Moor
Affiliation:
Department of Otolaryngology, Hull Royal Infirmary, UK
C J Woodhead
Affiliation:
Department of Otolaryngology, The Leeds General Infirmary, UK
K A Maclennan
Affiliation:
Department of Pathology, The Leeds General Infirmary, UK
*
Address for correspondence: Miss D Sylvester, Department of Otolaryngology, The Leeds General Infirmary, Great George Street, Leeds LS1 3AX, UK. E-mail: [email protected]

Abstract

Objective:

We report the second known case of aggressive angiomyxoma of the larynx.

Method:

Case report and a review of the world literature concerning angiomyxoma of the larynx and recent advances in the immunohistochemical, cytogenic and clinical study of its female pelvic counterpart.

Results:

Aggressive angiomyxoma is a rare mesenchymal tumour originally thought only to occur in the female pelvis and peritoneum, or rarely in the male genital tract. A 47-year-old man presented with a one-month history of dysphonia. He was found to have a supraglottic mass on endoscopic examination, and underwent a laryngofissure approach excision biopsy and covering tracheostomy. Histological analysis showed a characteristic proliferation of spindle cells widely separated by loose, myxoid stroma with a prominent vascular component. Aggressive angiomyxoma was diagnosed.

Conclusion:

To our knowledge, this is the second report in the world literature of aggressive angiomyxoma of the larynx. Comparison with the female pelvic counterpart facilitates diagnosis, aided by recent advances, and suggests that complete surgical excision with a wide margin is the treatment of choice.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Steeper, TA, Rosai, J. Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynaecologic soft-tissue neoplasm. Am J Surg Pathol 1983;7:463–75CrossRefGoogle ScholarPubMed
2Idrees, MT, Hoch, BL, Wang, BY, Unger, PD. Aggressive angiomyxoma of male genital region. Report of 4 cases with immunohistochemical evaluation including hormone receptor status. Ann Diagn Pathol 2006;10:197204CrossRefGoogle ScholarPubMed
3Teixeira de Maghalhaes, F, Pardal de Oliveira, F. Angiomyxoma of the larynx. Report of one case of a myxoid fibrohistiocytic lesion. Pathologica 1995;87:539–43Google Scholar
4Siassi, RM, Papadopoulos, T, Matzel, KE. Metastasizing aggressive angiomyxoma. N Engl J Med 1999;341:1772CrossRefGoogle ScholarPubMed
5Blandamura, S, Cruz, J, Faure Vergara, L, Machado Puerto, I, Ninfo, V. Aggressive angiomyxoma: a second case of metastasis with patient's death. Hum Pathol 2003;34:1072–4CrossRefGoogle ScholarPubMed
6Amezcua, CA, Begley, SJ, Mata, N, Felix, JC, Ballard, CA. Aggressive angiomyxoma of the female genital tract: a clinicopathologic and immunohistochemical study of 12 cases. Int J Gynecol Cancer 2005;15:140–5CrossRefGoogle ScholarPubMed
7van Roggen, JF, van Unnik, JAM, Briaire de Bruijn, IH, Hogendoorn, PCW. Aggressive angiomyxoma: a clinicopathological and immunohistochemical study of 11 cases with long-term follow-up. Virchows Arch 2005;446:157–63CrossRefGoogle ScholarPubMed
8Fetsch, JF, Laskin, WB, Lefkovitz, M, Kindblom, LG, Meis-Kindblom, JM. Aggressive angiomyxoma: a clinicopathological study of 29 female patients. Cancer 1996;78:79803.0.CO;2-4>CrossRefGoogle ScholarPubMed
9Kazmierczak, B, Wanschura, S, Meyer-Bolte, K, Caselitz, J, Meister, P, Bartnitzke, S et al. Cytogenetic and molecular analysis of an aggressive angiomyxoma. Am J Pathol 1995;147:580–5Google ScholarPubMed
10Nucci, MR, Weremowicz, S, Neskey, DM, Sornberger, K, Tallini, G, Morton, CC et al. Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva. Genes Chromosomes Cancer 2001;32:172–6CrossRefGoogle ScholarPubMed
11Micci, F, Panagopoulos, I, Bjerkehagen, B, Heim, S. Deregulation of HMGA2 in an aggressive angiomyxoma with t(11;12)(q23;q15). Virchows Arch 2006;448:838–42CrossRefGoogle Scholar
12Rabban, JT, Dal Cin, P, Oliva, E. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma. Int J Gynecol Pathol 2006;25:403–7CrossRefGoogle Scholar
13Fletcher, CDM, Unni, KK, Mertens, F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002Google Scholar
14McCluggage, WG, Jamieson, T, Dobbs, SP, Grey, A. Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin-releasing hormone agonist therapy. Gynecol Oncol 2006;100:623–5CrossRefGoogle ScholarPubMed